Clinical Trial Update: Retrospective Registry Providing Baseline Data on the Outcome of Left Atrial (LA) or LA Appendage (LAA) Thrombus in Patients With Nonvalvular Atrial Fibrillation (AF) or Atrial Flutter After Standard of Care (SoC) Anticoagulant Therapy

View source ↗

Summary

A Bayer-sponsored retrospective registry provides baseline data on the outcome of left atrial (LA) or left atrial appendage (LAA) thrombus in patients with nonv…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Atrial Flutter

Snippet

Sponsor: Bayer | Conditions: Atrial Fibrillation | Status: COMPLETED